previous compound ID: 292 next compound
InChIKey: BXDAOUXDMHXPDI-UHFFFAOYSA-N
SMILES: CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F.Cl.Cl

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"R Robert" "GW Carlile" "B Kus" "D Rotin" "J Goepp" "J Liao" "SD Macknight" "E Matthes" "DY Thomas" "JW Hanrahan"

chemical graph of compound 292





CID is 66064
synonyms found at PubChem are:
Trifluoperazine dihydrochloride, 440-17-5, Trifluoperazine hydrochloride, Terfluzine, Stelazine, Triphthazine, Eskazinyl, Jatroneural, Tryptazine, Trazine, Trifluoperazine 2HCl, Trifluoperazine HCl, Fluoperazine, Eskazine, Triftazin, Trifluoroperazine hydrochloride, Tryptazine dihydrochloride, Triphthazine dihydrochloride, Calmazine, Stalazine hydrochloride, Stelazine dihydrochloride, UNII-6P1Y2SNF5V, Modalina, Trifluoroperazine dihydrochloride, Trifluoperazine (dihydrochloride), SKF 5019, Trifluoperazine hydrochloride (VAN), Trifluperazine dihydrochloride, 10-[3-(4-Methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)-10H-phenothiazine dihydrochloride, EINECS 207-123-0, Fluoperazine dihydrochloride, 6P1Y2SNF5V, 10-(3-(4-methylpiperazin-1-yl)propyl)-2-(trifluoromethyl)-10H-phenothiazine dihydrochloride, AI3-50137, Trifluoperazine hydrochoride, Stelazine (TN), 10-(3-(4-Methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)phenothiazine dihydrochloride, 10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine dihydrochloride, 10H-Phenothiazine, 10-(3-(4-methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)-, dihydrochloride, 10H-phenothiazine, 10-[3-(4-methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-, dihydrochloride, DSSTox_CID_25085, DSSTox_RID_80660, DSSTox_GSID_45085, 2-Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine dihydrochloride, CHEBI:9710, Phenothiazine, 10-(3-(4-methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)-, dihydrochloride, 10H-Phenothiazine,10-[3-(4-methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-, hydrochloride (1:2), SR-01000003020, NCGC00186653-01, CAS-440-17-5, 10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine;dihydrochloride, 10H-Phenothiazine, 10-(3-(4-methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)-, hydrochloride (1:2), 10H-Phenothiazine, 10-[3-(4-methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-, hydrochloride (1:2), Trifluoperazine hydrochloride [JAN], Prestwick_482, Trifluoperazine diHCl, Trifluoperazine maleate, Trifluoperazine hydrochloride [USP:JAN], AC1L24JK, TrifluoperazineDihydrochloride, C21H26Cl2F3N3S, SCHEMBL341516, SPECTRUM1500591, Trifluroperazine dihydrochloride, CHEMBL1257040, DTXSID1045085, CTK4I7934, HY-B0532A, BXDAOUXDMHXPDI-UHFFFAOYSA-N, MolPort-000-917-737, HMS1568P08, HMS1921G15, KS-000012JG, SKF-5019, Tox21_110017, Tox21_501232, CCG-40290, MFCD00012656, s3201, AKOS015895085, Tox21_110017_1, AC-8081, AN-8371, CS-2756, KS-5109, LP01232, NE57070, NCGC00013226-01, NCGC00094474-01, NCGC00094474-02, NCGC00094474-03, NCGC00261917-01, Trifluoperazine hydrochloride (JAN/USP), LS-105596, EU-0101232, FT-0600798, D00799, T 8516, Trifluoperazine dihydrochloride, >=99%, powder, I06-0498, SR-01000003020-2, W-106212, SR-01000003020-10, Trifluoperazine hydrochloride, meets USP testing specifications, Trifluoperazine Hydrochloride 1.0 mg/ml in Methanol (as free base), 2-Trifluoromethyl-10-[3-(1-methyl-4-piperazinyl)propyl]phenothiazine dihydrochloride, Trifluoperazine hydrochloride, European Pharmacopoeia (EP) Reference Standard, Trifluoperazine hydrochloride, United States Pharmacopeia (USP) Reference Standard, Trifluoperazine dihydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, 10-[3-(4-methylpiperazinyl)propyl]-2-(trifluoromethyl)phenothiazine, chloride, chloride, MolPort-000-712-016, SBB057670, AKOS024370856, MCULE-1362676470, ST51006785, AKOS026750064